Dates for your diary

British Breast Cancer Research Conference, Nottingham, 15-17 September 2010.

Breast Imaging Research Network meeting, Brighton. 31 October 2010

RCRBG Annual Scientific meeting, Brighton. 1-2 November 2010. Abstract submission closes 31 July

RSNA, Chicago, 28 November - 4 December 2010.

EUSOBI, Vienna, 2 – 3 March 201

ECR, Vienna, 3 – 7 March 2011. Abstract submission opens 5 July; closes 18 September.

CAMBRIDGE Breast Cancer Imaging Conference
28-19 March, 2011

 

 

 

Welcome to the home pages of the Royal College of Radiologists Breast Group

We are a specialist group of radiologists working in breast imaging in the UK

Membership includes associate members, such as breast clinicians, who are medically qualified members of the breast team. Also advanced practitioners/consultant practitioners (radiographic technologists) who have extended their roles in film reading, ultrasound and biopsies are allied to our group.

How to Join the Breast Group

 

 

  • 2010 ASM

  • The Breast Course

  • Digital Purchasing

  • NCEPOD

  • IE Portal

BRIGHTON 2010 Annual Scientific Meeting

Programme and Call for Abstracts
Registration
Abstracts via Hampton's

UPDATED PROGRAMME (July 2010)

Research abstracts for the ASM will be published in Breast Cancer Research

NOTE: Abstract submission deadline - FRIDAY 30th JULY 2010

THE BREAST COURSE - The course is primarily for radiologists and focuses on image guided techniques with live demonstrations of all the core and vacuum techniques and cryo-ablation. There are also hands on work shops with all the devices available to try. Big on MR as well with Steve Harms and Christiane Kuhl doing lots of workshops. Tom Stavros is also a main contributor doing plenary lectures and workshops focused on specific problem areas. There is input from top end oncologists, pathologists and surgeons (including Emiel Rutgers from the Erasmus in Holland) as well. The faculty are also around all the time for one to one sessions - www.thebreastcourse.com

DOCUMENTS AVAILABLE on Digital Mammography
NHS Purchasing and Supply Website info

  1. CEP cost effectiveness study on digital versus film/screen mammography
  2. Buyers Guide to Digital Mammography
  3. Also there is an interactive guide available
NCEPOD (National confidential enquiry into patient outcome and death) who are asking for submissions of original study proposals - see PDF file

The Image Exchange Portal (IEP) is a web-based application that allows healthcare professionals to securely transfer patient images from one hospital trust to another. The system has been deployed in increasing numbers of trusts since January 2010 and significant benefits are already being realised for both hospital staff and patients.
IEP was designed to eliminate the costly production of CDs, streamline radiology reporting and improve the patient experience. It’s expected that 120 trusts will be using IEP by June 2010. By this time some 20,000 patient studies will have been transferred using the system, significantly reducing the number of patient images that have to be burned to CD and sent via costly courier services.
PACS medical director Erika Denton says that IEP “is a major step towards ensuring that diagnostic imaging information can be shared along a patient’s care pathway in a secure way”.

more.... (pdf)

 

 

 

 

 

 

 

Guidelines from the American College of Radiology

- permission has been granted by the ACR for us to link to their practice guidelines and appropriateness criteria

These are somewhat similar to the UK Guidelines and MBUR tables, but in more detail. They are well work a look

Practice Guidelines
Appropriateness Criteria

 

 

 

Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know



Mizuki Nishino, Jyothi P. Jagannathan, Nikhil H. Ramaiya, and Annick D. Van den Abbeele
AJR 2010;195:281-289

Link to Journal

The original RECIST guideline, version 1.0, provided definitions for "measurable lesion" and "nonmeasurable lesion". Measurable lesions must have a longest diameter of ≥ 10 mm on CT with a slice thickness of ≤ 5 mm (or a longest diameter of ≥ 20 mm on  nonhelical CT with a slice thickness of > 10 mm) or a longest diameter of ≥ 20 mm on chest radiography

RECIST assigns four categories of response: complete response (CR), partial response (PR), stable disease (SD), and progressive disease (PD). Assessment of overall response is based on the evaluations of target and nontarget lesions at each follow-up time point. The measurements and response assessment are often recorded using tumor measurement tables.

Major changes in RECIST 1.1 related to imaging include the following: first, the number of target lesions; second, assessment of pathologic lymph nodes; third, clarification of disease progression; fourth, clarification of unequivocal progression of nontarget lesions; and, fifth, inclusion of 18F-FDG PET in the detection of new lesions. The number of target lesions to be assessed was reduced from five per organ to two per organ and from a maximum of 10 target lesions total to a maximum of five total.

In RECIST 1.0, there was no clear guideline for lymph node measurement.  In RECIST 1.1, detailed instructions about how to measure and assess lymph nodes are provided. Lymph nodes with a short axis of ≥ 15 mm are considered measurable and assessable as target lesions, and the short-axis measurement should be included in the sum of target lesion measurements in the calculation of tumor response as opposed to the longest axis used for measurements of other target lesions

CONCLUSION:
Familiarity with the revised RECIST is essential  in day-to-day oncologic imaging practice to provide up-to-date service to oncologists and their patients. Some of the changes in the revised RECIST affect how radiologists select, measure, and report target lesions

 

© Dr Chris Flowers, 2001-2010